A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
about
Screening from the world's largest TCM database against H1N1 virus.Structure and stability analysis of cytotoxic complex of camel α-lactalbumin and unsaturated fatty acids produced at high temperature.High performance screening, structural and molecular dynamics analysis to identify H1 inhibitors from TCM Database@Taiwan.Potential retinoid x receptor agonists for treating Alzheimer's disease from traditional chinese medicine.In Silico Investigation of Potential PARP-1 Inhibitors from Traditional Chinese Medicine.Treatment of acute lymphoblastic leukemia from traditional chinese medicineIn search of allosteric modulators of a7-nAChR by solvent density guided virtual screening.Treatment of cardiovascular disease by traditional Chinese medicine against pregnane X receptorPotential smoothened inhibitor from traditional Chinese medicine against the disease of diabetes, obesity, and cancerThree-in-one agonists for PPAR-α, PPAR-γ, and PPAR-δ from traditional Chinese medicine.First principles calculations of thermodynamics and kinetic parameters and molecular dynamics simulations of acetylcholinesterase reactivators: can mouse data provide new insights into humans?Identification of novel peroxisome proliferator-activated receptor-gamma (PPARγ) agonists using molecular modeling method.Biological evaluation and interaction of a newly designed anti-cancer Pd(II) complex and human serum albumin.Molecular modeling studies of Yersinia pestis dihydrofolate reductase.Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.Search for novel remedies to augment radiation resistance of inhabitants of Fukushima and Chernobyl disasters: identifying DNA repair protein XRCC4 inhibitors.Molecular modeling of Mycobacterium tuberculosis dUTpase: docking and catalytic mechanism studies.Insight into the inhibitory mechanism and binding mode between D77 and HIV-1 integrase by molecular modeling methods.Traditional Chinese medicine, a solution for reducing dual stroke risk factors at once?In silico pharmacology suggests ginger extracts may reduce stroke risks.Design of new chemotherapeutics against the deadly anthrax disease. Docking and molecular dynamics studies of inhibitors containing pyrrolidine and riboamidrazone rings on nucleoside hydrolase from Bacillus anthracis.Traditional Chinese medicine as dual guardians against hypertension and cancer?Investigation into potent inflammation inhibitors from traditional Chinese medicine.iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design.Potent inhibitor design against H1N1 swine influenza: structure-based and molecular dynamics analysis for M2 inhibitors from traditional Chinese medicine database.Biphasic association of T7 RNA polymerase and a nucleotide analogue, cibacron blue as a model to understand the role of initiating nucleotide in the mechanism of enzyme action.BetaDock: shape-priority docking method based on beta-complex.Compounds of the 1,5-di(4-R-phenyl)- 3-selenopentanediones-1,5 series interaction with the basidiomycete Lentinula edodes lectins: computations and experiment.Mechanism of BAG1 repair on Parkinson's disease-linked DJ1 mutation.Pharmacophore modeling and hybrid virtual screening for the discovery of novel IκB kinase 2 (IKK2) inhibitors.The flexibility of P-glycoprotein for its poly-specific drug binding from molecular dynamics simulations
P2860
Q30399346-F3B43313-0A89-44A8-8CD7-64238AA5EC5BQ30401575-7FC91820-7F5C-4BE4-96B5-B505377918F9Q30408391-D765D7A3-F424-45FD-869C-0353859BF3CAQ33614602-59A45B51-DCD1-471E-A16C-C316214D326BQ33614632-39E700DA-DF88-4886-9237-5B791392F1B2Q33746550-D739BC42-B25C-4A20-BB05-0FEC26948478Q33811917-6A253265-72ED-4DF6-AA9D-94AB5B233953Q33876600-288AF401-2290-4B8F-8DAF-5B8FE780E914Q34022289-DEE9A25A-5B7B-41F2-8F7C-60CD31C062CBQ34316470-4D1C3E1B-13EB-4EBF-99B9-3035600A4D5FQ34316593-A0F162C4-C507-49BA-AC4E-27B73A5F8213Q35234394-AB43A8BA-11DC-4F4C-8D91-E804A4CFBE2AQ39482778-805AB0D1-094D-46AE-97CC-9F00D4D86E5DQ41426709-B64EC58B-B9E0-4B83-909C-0372E681AFC8Q41932456-70CCBD30-730A-47D0-AD8E-6013C30928A5Q41980724-B72EED16-7E55-43F3-BAAB-DF7DE0C97070Q43414532-96BC02C5-C487-4C1E-A951-95E3690082A1Q45330213-F1683D4B-9339-4634-8A64-C5174E081369Q45961690-FAF30828-2905-49B7-804B-AC8162263CE2Q45961735-950F58B1-A239-4056-9EFB-01C86F031E2DQ46159949-EB44B546-AECC-4B25-80B9-CCB2767A9548Q47197241-94124FCE-1A7B-4D5A-8872-C03FA7740F05Q47278490-889106F6-A27A-45F3-8284-423AFF056EE6Q47287940-A38424B9-7CDD-4965-9EA4-CB9FDED33F64Q47337151-1A2E88EB-0260-4500-A43C-64CC8BFE9E87Q50275626-D36AA4A1-5B9F-4CF9-A4F6-221A3863D08EQ51555332-B4C4F0B0-3271-4E0C-96DC-861CEF3CB9FBQ51602625-4C183611-11D0-4409-B08A-ED3F97EBDF86Q52625121-A5B22987-75CF-457E-B409-F2B4B564A0FAQ53419138-AA02F42D-B9A6-40BC-8B88-63A88272DC17Q58195302-53691E24-B10D-4286-94FC-F556FC4A2162
P2860
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@en
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@nl
type
label
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@en
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@nl
prefLabel
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@en
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@nl
P2093
P2860
P1476
A novel strategy for designing the selective PPAR agonist by the "sum of activity" model.
@en
P2093
Calvin Yu-Chian Chen
Fuu-Jen Tsai
Hsin Wei Yu
Hsin-Yi Chen
Hung-Jin Huang
Kuei-Jen Lee
P2860
P304
P356
10.1080/07391102.2010.10507352
P577
2010-10-01T00:00:00Z